Peer-influenced content. Sources you trust. No registration required. This is HCN.
Mayo Clinic Labs
Poor metabolizers of UGT1A1 face a significantly increased risk of severe neutropenia from irinotecan therapy, making genetic testing crucial for appropriate dose modification.
Clinical Pharmacology December 3rd 2024
The New England Journal of Medicine
The presence of hypophosphatemic rickets with elevated FGF23 levels in conjunction with classical features provides crucial diagnostic insights for clinicians evaluating pediatric bone disorders.
Medical Genetics November 27th 2024
Epoch Health
Large-scale analysis of 5.1 million individuals reveals distinct correlations between blood types and 49 different diseases, offering new perspectives for risk assessment in clinical practice.
Cardiology November 25th 2024
Recent research suggests microbiome composition may serve as a predictor for ASD, opening new avenues for diagnostic approaches and therapeutic interventions.
Family Medicine/General Practice October 29th 2024
Cleveland Clinic Journal of Medicine
Bevacizumab therapy demonstrated marked improvement in both epistaxis severity and abdominal symptoms, despite unchanged radiographic appearance of hepatic AVMs, suggesting therapeutic benefit at the microvasculature level.
Gastroenterology October 28th 2024
Medical Xpress
The study found that frequent use of high-potency cannabis is associated with changes in genes related to mitochondrial and immune function, particularly affecting the CAVIN1 gene.
Internal Medicine October 21st 2024